OUR VACCINE PIPELINE


From Bench to Clinic

AAHI is uniquely positioned to support development of products based on our immune-enhancing platforms from bench to clinic. Our capabilities place AAHI at the intersection of emerging sciences, medicine, and the business of biotech, enabling us to provide technologies, services, and insights that advance the state-of-the art for the entire biomedical community.

Alleviating Disease Around the World

INDICATION

Preclinical

GMP/Tox

Phase 1

Phase 2

Phase 3

COVID-19

Protein Vaccine Candidates








RNA Vaccine






Tuberculosis

Protein Vaccine Candidates








RNA Vaccine




HIV

Protein Vaccine Candidates








RNA Vaccine




Flavivirus

RNA Vaccine





Pandemic Influenza

RNA Vaccine

Spray-dried




RNA Vaccine

Bivalent (H7N9, H5N1)



Malaria

Protein Vaccine Candidates 







Hepatitis C

Protein Vaccine

Candidate







Neglected Tropical Diseases

Hookworm





Schistosomiasis 




Schistosomiasis





Leprosy